Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemia. - Montalban-Bravo G; Ma F; Thongon N; Yang H; Gomez IG; Rodriguez-Sevilla JJ; Adema V; Wildeman B; Lockyer P; Kim YJ; Tanaka T; Darbaniyan F; et al. (BioRxiv : the preprint server for biology, 2023)